Loading company…
Pittsburgh company founded in 2015 that is developing a dissolvable microneedle patch to treat basal and squamous cell skin cancers.
SkinJect Inc., founded in 2015 and headquartered in Pittsburgh, US, focuses on dermatological solutions. Its main product is a dissolvable microneedle patch for basal and squamous cell skin cancers, aimed at dermatologists, oncologists and patients in the US. James Nolan is CEO. The company has raised USD 2.50 mn in total, including a USD 0.90 mn venture debt round in July 2021.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in